Sputnik V (Russian: Спутник V, the brand name from the Russian Direct Investment Fund or RDIF) or Gam-COVID-Vac (Russian: Гам-КОВИД-Вак, the name under which it is legally registered and produced [4]) is an adenovirus viral vector vaccine for COVID-19 developed by the Gamaleya Research Institute of Epidemiology and Microbiology in Russia.

Jul 6, 2021 · Sputnik V — also known as Gam-COVID-Vac — was the first COVID-19 vaccine to be registered for use in any nation, and it has since been approved in 67 countries, including Brazil, Hungary,...

A promising aspect of Sputnik V is that it is a “heterologous prime-boost” vaccine, which means the first and second doses differ. Each dose uses a different adenovirus vector to get the coronavirus spike protein DNA into human cells.

Gamaleya Sputnik V, or Gam-COVID-Vac, is a viral two-vector vaccine based on two strains of common cold human adenoviruses, Ad26 and Ad5, also containing a gene encoding the SARS-CoV-2 spike protein . All three vaccines require two-part administration, with a booster dose suggested in six months.

Jul 27, 2021 · What kind of vaccine is Sputnik V, how does it work, and what data are we missing? Growing evidence suggests Russia’s Sputnik V COVID vaccine is safe and very effective. But questions about...

The Sputnik V COVID-19 vaccine is a member of the so-called vector vaccines and uses two different vectors (Ad26 priming and Ad5 boost) to reduce the risk of a reduction in the effectiveness of the vaccination. Real life data indicate an efficacy of ...

Sputnik Light is the first component (recombinant human adenovirus serotype number 26 (rAd26)) of the Sputnik V coronavirus vaccine. The single dose Sputnik Light vaccine demonstrated 79.4% efficacy according to analyzed data taken from 28 days after the injection was administered.

Feb 2, 2021 · An interim analysis of Russia’s Sputnik V vaccine has found it to be 91.6% effective against symptomatic Covid-19 and 100% effective against severe and moderate disease.

Official data on Sputnik V around the world confirms its highest safety and efficacy profile. Real data provided by cooperation of RDIF and various Health Ministries

Feb 2, 2021 · Russia's Sputnik V coronavirus vaccine gives around 92% protection against Covid-19, late stage trial results published in The Lancet reveal. It has also been deemed to be safe - and offer...